Literature DB >> 19426604

Signaling pathways regulating vascular smooth muscle cell differentiation.

Eva M Rzucidlo1.   

Abstract

Vascular smooth muscle cell (VSMC) differentiation is an essential component of vascular development. These cells perform biosynthetic, proliferative, and contractile roles in the vessel wall. VSMCs are not terminally differentiated and are able to modulate their phenotype in response to changing local environmental cues. There is clear evidence that alterations in the differentiated state of the VSMC play a critical role in the pathogenesis of atherosclerosis and intimal hyperplasia, as well as in a variety of other major human diseases, including hypertension, asthma, atherosclerosis and vascular aneurysms. The focus of this review is to provide an overview of the current state of knowledge of molecular mechanisms involved in controlling phenotypic switching of VSMCs, with particular focus on examination of the signaling pathways that regulate this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426604     DOI: 10.2310/6670.2008.00089

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  12 in total

1.  MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1.

Authors:  Yumei Li; Limei Yan; Wenyu Zhang; Nan Hu; Wei Chen; Hui Wang; Min Kang; Hesheng Ou
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries.

Authors:  Xue Peng; Hong-Xia Li; Hong-Jiang Shao; Guang-Wei Li; Jian Sun; Yu-Hui Xi; Hong-Zhu Li; Xin-Yan Wang; Li-Na Wang; Shu-Zhi Bai; Wei-Hua Zhang; Li Zhang; Guang-Dong Yang; Ling-Yun Wu; Rui Wang; Chang-Qing Xu
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

3.  TSH stimulates the proliferation of vascular smooth muscle cells.

Authors:  Limin Tian; Jing Ni; Tiankang Guo; Jing Liu; Yamei Dang; Qian Guo; Luyan Zhang
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

Review 4.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

5.  Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function.

Authors:  Dan Yu; George Makkar; Rajabrata Sarkar; Dudley K Strickland; Thomas S Monahan
Journal:  J Vis Exp       Date:  2017-06-11       Impact factor: 1.355

6.  Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse.

Authors:  Corey S Moran; Roby J Jose; Erik Biros; Jonathan Golledge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-09       Impact factor: 8.311

7.  Silencing a disintegrin and metalloproteinase‑33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling.

Authors:  Fang Yan; Yanyan Hao; Xinji Gong; Hu Sun; Jianbing Ding; Jing Wang
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

Review 8.  Neo-intimal hyperplasia, diabetes and endovascular injury.

Authors:  Deirdre Kruger
Journal:  Cardiovasc J Afr       Date:  2012-05-22       Impact factor: 1.167

9.  Andrographolide inhibits nuclear factor-κB activation through JNK-Akt-p65 signaling cascade in tumor necrosis factor-α-stimulated vascular smooth muscle cells.

Authors:  Yu-Ying Chen; Ming-Jen Hsu; Cheng-Ying Hsieh; Lin-Wen Lee; Zhih-Cherng Chen; Joen-Rong Sheu
Journal:  ScientificWorldJournal       Date:  2014-07-10

10.  Regulatory role of mammalian target of rapamycin signaling in exosome secretion and osteogenic changes in smooth muscle cells lacking acid ceramidase gene.

Authors:  Owais M Bhat; Xinxu Yuan; Rakesh C Kukreja; Pin-Lan Li
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.